UBS Maintains Neutral on Stryker, Lowers Price Target to $380

Benzinga Newsdesk www.benzinga.com Negative 77.6%

Neg 77.6% Neu 0% Pos 0%

UBS analyst Danielle Antalffy maintains Stryker (NYSE:SYK) with a Neutral and lowers the price target from $400 to $380.